Medical shots also known as vaccines are made from ingredients which include antigens, and, stabilizers, preservatives and trace manufacturing elements.
Antigens in vaccines are the active ingredient that is made from dead or weakened viruses, bacteria or a snippet of genetic material like "mRNA", which teaches the immune system in the body to fight off a disease.
Adjuvants in vaccines are additives like aluminum salts or squalene oil that is found naturally in the body, which also boosts your body's immune response so that the shot provides stronger, longer lasting protection.
Stabilizers in vaccines, like sugars or sucrose or gelatin that keep the ingredients in the vaccine from breaking down when exposed to temperature changes.
And ingredients like thimerosal (ethylmercury), are used in vaccines in very small quantities in some multi dose vials to prevent the growth of bacteria and fungi.
And trace amounts of antibiotics like neomycin are added to vaccines to prevent bacterial contamination or residual material from cell cultures, like egg protein.
Developing a vaccine is not a quick or easy process.
It takes around 10 to 15 years to develop a vaccine and is a long process that requires rigorous laboratory research, animal testing and three phases of human clinical trials.
The process of developing vaccines for humans culminates in strict regulatory review as well as large scale manufacturing and ongoing safety monitoring to ensure that it is safe and effective for the public to use.
Creating a safe and effective human vaccine involves several distinct, highly regulated stages, which include:
1: Research and Discovery, in which scientists study the target pathogen (the virus or bacteria) to understand how it causes illness and which parts of it trigger your immune system.
They also design the vaccine using a vaccine using either the whole microwave (weakened or inactivated), genetic material (like mRNA), or harmless pieces of the pathogen's proteins.
2: Pre-Clinical Testing, where before being tested in humans, the vaccine candidate undergoes laboratory and animal testing.
And researchers administer the vaccine to small animals like mice or rabbits first and often larger animals to evaluate if it creates a strong immune response and is safe enough for human trials.
3: Clinical Trials in Humans.
The U.S. Food and Drug Administration (FDA) reviews pre-clinical data before authorizing testing in humans.
Human trials occur in three sequential phases:
Phase I: The vaccine is given to a small group of healthy volunteers (usually 20 to 100) to assess basic safety, determine the correct dosage, and check for immune reactions.
Phase II: The trial is expanded to several hundred participants who reflect the demographic target of the vaccine (e.g., age, health status).
This phase further evaluates safety, side effects, and how the immune system responds.
Phase III: The vaccine is administered to thousands or tens of thousands of people across multiple sites.
Researchers compare vaccinated individuals with a control group (who receive a placebo) to definitively prove the vaccine's efficacy in preventing disease and identifying rare side effects.
4: Regulatory Approval and Licensure.
Developers then submit a Biologics License Application (BLA) containing all clinical data to the FDA.
Regulatory experts carefully review this data to determine whether the vaccine's benefits outweigh its risks.
5: Manufacturing and Quality Control.
Concurrent with trials and approval, developers must figure out how to mass-produce the vaccine safely and consistently.
Every single batch is strictly tested for sterility, potency, and purity before it is released to the public.
6: Post Approval Monitoring.
Even after a vaccine is widely distributed, organizations like the FDA and the Centers for Disease Control and Prevention (CDC) continue to track its safety through monitoring systems to identify any rare or long-term adverse events.